Moore v. Bayer HealthCare Pharmaceuticals Inc. et al

Filing 6

STIPULATION AND ORDER EXTENDING TIME TO ANSWER re 5 Stipulation filed by Bayer HealthCare Pharmaceuticals Inc.. Signed by Judge Edward M. Chen on 8/12/10. (bpf, COURT STAFF) (Filed on 8/12/2010)

Download PDF
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 DRINKER BIDDLE & REATH LLP A T T O R N E Y S A T LAW S A N FR A N C I S C O RODNEY M. HUDSON (SBN #189363) rodney.hudson@dbr.com DRINKER BIDDLE & REATH LLP 50 Fremont Street, 20th Floor San Francisco, CA 94105-2235 Telephone: (415) 591-7500 Facsimile: (415) 591-7510 Attorneys for Defendants BAYER HEALTHCARE PHARMACEUTICALS, INC. UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION DAVID MOORE, INDIVIDUALLY AND ON BEHALF OF THE ESTATE OF KATHRYN C MOORE AND ALL LEGAL BENEFICIARIES, Plaintiffs, v. BAYER HEALTHCARE PHARMACEUTICALS, INC.; BAYER SCHERING PHARMA AG; GE HEALTHCARE, INC.; GE HEALTHCARE AS; MALLINCKRODT, INC.; and BRACCO DIAGNOSTICS, INC., Defendants. Case No. CV 10 3181 EMC STIPULATION OF PLAINTIFF AND DEFENDANT BAYER HEALTHCARE PHARMACEUTICALS, INC. TO EXTEND TIME FOR DEFENDANT TO FILE A RESPONSIVE PLEADING ; ORDER Pursuant to Local Rule 6-1 of the United States District Court for the Northern District of California, and based on the agreement between counsel for Plaintiff David Moore, individually and on behalf of the estate of Kathryn Moore and all legal beneficiaries, and Defendant Bayer Healthcare Pharmaceuticals, Inc., it is hereby stipulated as follows: The parties agree that the period of time within which Defendant Bayer Healthcare Pharmaceuticals, Inc. may answer or otherwise respond to the Complaint is extended until after STIP. OF PLAINTIFF AND BHCP, INC. TO EXTEND TIME FOR BHCP TO FILE A RESPONSIVE PLEADING SF01/ 701145.1 CASE NO. CV 10 3181 EMC 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 DRINKER BIDDLE & REATH LLP A T T O R N E Y S A T LAW S A N FR A N C I S C O the case is transferred to In Re: Gadolinium Based Contrast Agents Products Liability Litigation, MDL No. 1909, Case No. 1:09-gd-50000-DAP ("MDL"), pending in the United States District Court of the Northern District of Ohio. Upon transfer, Defendant Bayer Healthcare Pharmaceutical, Inc.'s obligation to file a responsive pleading will be governed by Case Management Order No. 5 issued in the MDL. Dated: August 11, 2010 DRINKER BIDDLE & REATH LLP By:/s/ Rodney M. Hudson Rodney M. Hudson Attorneys for Defendants BAYER HEALTHCARE PHARMACEUTICALS, INC. Dated: August 11, 2010 LEVIN SIMES KAISER & GORNICK LLP By: /s/ Laura Brandenberg (with permission) Laura Brandenberg ATTORNEYS FOR PLAINTIFF DAVID MOORE, INDIVIDUALLY AND ON BEHALF OF THE ESTATE OF KATHRYN MOORE AND ALL LEGAL BENEFICIARIES IT IS SO ORDERED: ER N F D IS T IC T O R STIP. OF PLAINTIFF AND BHCP, INC. TO EXTEND TIME FOR BHCP TO FILE A RESPONSIVE PLEADING SF01/ 701145.1 -2- A C LI FO dward Judge E M. Che n R NIA __________________ D Edward M. Chen RDERE S SO O U.S. Magistrate JudgeIT I UNIT ED S S DISTRICT TE C TA RT U O NO RT H CASE NO. CV 10 3181 EMC

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?